Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
Navas-Acien A, Santella RM, Joubert BR, Huang Z, Lokhnygina Y, Ujueta F, Gurvich I, LoIacono NJ, Ravalli F, Ward CD, Jarrett JM, Salazar AL, Boineau R, Jones TLZ, Mark DB, Newman JD, Nathan DM, Anstrom KJ, Lamas GA.
Navas-Acien A, et al. Among authors: jones tlz.
Am Heart J. 2024 Apr 15;273:72-82. doi: 10.1016/j.ahj.2024.04.005. Online ahead of print.
Am Heart J. 2024.
PMID: 38621575